BioMarin Pharmaceuticals
BMRN
BMRN
554 hedge funds and large institutions have $16.3B invested in BioMarin Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 195 increasing their positions, 202 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
554
Holders Change
+12
Holders Change %
+2.21%
% of All Funds
8.03%
Holding in Top 10
6
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-57.14%
% of All Funds
0.09%
New
66
Increased
195
Reduced
202
Closed
51
Calls
$181M
Puts
$222M
Net Calls
-$41.1M
Net Calls Change
-$92.5M
Top Buyers
1 |
UBS Group
Zurich,
Switzerland
|
+$434M |
2 |
Citadel Advisors
Miami,
Florida
|
+$142M |
3 |
Viking Global Investors
Stamford,
Connecticut
|
+$133M |
4 |
Millennium Management
New York
|
+$96.8M |
5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$77.8M |